Stress-Induced Locomotor Sensitization to Amphetamine in Adult, but not in Adolescent Rats, Is Associated with Increased Expression of ΔFosB in the Nucleus Accumbens.
While clinical and pre-clinical evidence suggests that adolescence is a risk period for the development of addiction, the underlying neural mechanisms are largely unknown. Stress during adolescence has a huge influence on drug addiction. However, little is known about the mechanisms related to the interaction among stress, adolescence and addiction. Studies point to ΔFosB as a possible target for this phenomenon. In the present study, adolescent and adult rats (postnatal day 28 and 60, respectively) were restrained for 2 h once a day for 7 days. Three days after their last exposure to stress, the animals were challenged with saline or amphetamine (1.0 mg/kg i.p.) and amphetamine-induced locomotion was recorded. Immediately after the behavioral tests, rats were decapitated and the nucleus accumbens was dissected to measure ΔFosB protein levels. We found that repeated restraint stress increased amphetamine-induced locomotion in both the adult and adolescent rats. Furthermore, in adult rats, stress-induced locomotor sensitization was associated with increased expression of ΔFosB in the nucleus accumbens. Our data suggest that ΔFosB may be involved in some of the neuronal plasticity changes associated with stress induced-cross sensitization with amphetamine in adult rats.
Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University-UNESP Araraquara, Brazil.
Paulo E
PE
Carneiro de Oliveira
Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University-UNESP Araraquara, Brazil.
Rodrigo M
RM
Leão
Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University-UNESPAraraquara, Brazil; Joint Graduate Program in Physiological Sciences, UFSCar/UNESP, Faculdade de Odontologia de AraraquaraAraraquara, Brazil.
Paula C
PC
Bianchi
Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University-UNESPAraraquara, Brazil; Joint Graduate Program in Physiological Sciences, UFSCar/UNESP, Faculdade de Odontologia de AraraquaraAraraquara, Brazil.
Marcelo T
MT
Marin
Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University-UNESPAraraquara, Brazil; Joint Graduate Program in Physiological Sciences, UFSCar/UNESP, Faculdade de Odontologia de AraraquaraAraraquara, Brazil.
Cleopatra da Silva
Cda S
Planeta
Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University-UNESP Araraquara, Brazil.
Fábio C
FC
Cruz
adolescence; amphetamine; behavioral sensitization; stress; ΔFosB
Biol Psychiatry. 2011 Sep 1;70(5):487-95
21679928
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
18640920
Pharmacol Biochem Behav. 2010 Aug;96(2):160-5
20460138
Neuron. 1994 Nov;13(5):1235-44
7946359
Curr Top Behav Neurosci. 2010;3:179-95
21161753
Nat Neurosci. 2003 Nov;6(11):1208-15
14566342
J Neurosci. 1997 Jul 1;17(13):4933-41
9185531
J Neurosci. 2000 Dec 15;20(24):8965-71
11124971
Pharmacol Ther. 2008 Nov;120(2):102-28
18789966
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):163-78
12732232
Brain Res. 2004 Jul 2;1013(1):83-90
15196970
J Neurosci. 2010 Oct 27;30(43):14585-92
20980616
Brain Res Dev Brain Res. 1995 Nov 21;89(2):167-72
8612321
J Neural Transm (Vienna). 2012 Apr;119(4):415-24
22006016
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3399-404
16492766
Psychopharmacology (Berl). 2011 May;215(1):165-75
21197616
Life Sci. 1985 Sep 16;37(11):1039-42
4041000
Alcohol Res Health. 2000;24(2):115-23
11199278
Physiol Behav. 2009 Jun 22;97(3-4):484-94
19345235
Neurosci Biobehav Rev. 1999 Nov;23(7):993-1010
10580313
Eur J Pharmacol. 2015 Apr 15;753:66-72
25446562
Mol Pharmacol. 1995 Nov;48(5):880-9
7476919
J Neurosci. 2012 Jul 25;32(30):10267-72
22836260
J Neurosci. 2013 Mar 13;33(11):4913-22
23486962
Brain Res Dev Brain Res. 2002 Sep 20;138(1):27-34
12234655
Psychopharmacology (Berl). 2015 May;232(9):1555-69
25373870
Eur J Neurosci. 2008 Jan;27(1):191-201
18184321
Psychopharmacology (Berl). 2001 Dec;158(4):388-98
11797060
Brain Res Mol Brain Res. 2004 Dec 20;132(2):146-54
15582154
Drug Discov Today Dis Models. 2008 Winter;5(4):259-270
20016773
Nature. 1999 Sep 16;401(6750):272-6
10499584
J Neurosci. 2003 Mar 15;23(6):2488-93
12657709
Behav Brain Res. 2002 Mar 10;130(1-2):117-25
11864727
J Neurosci. 2013 Feb 20;33(8):3434-42
23426671
J Neurosci. 2004 Nov 24;24(47):10594-602
15564575
Dev Psychobiol. 1983 Mar;16(2):83-109
6339302
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3245-55
18640924
Neurochem Int. 1998 Oct;33(4):287-97
9840219
Psychopharmacology (Berl). 2008 Jan;196(1):71-81
17922112
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
10817843
Biol Psychiatry. 2001 Jun 15;49(12):1023-39
11430844
Physiol Behav. 1997 Dec 31;63(1):143-5
9402627
Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
10972458
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11042-6
11572966
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10523-8
12939407
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):19-31
12732220
Behav Brain Res. 2011 Feb 2;217(1):155-64
20974185
AIDS Behav. 2011 May;15(4):869-74
20107887
Brain Res. 1999 Jul 17;835(1):10-7
10448191
Pharmacol Biochem Behav. 2002 Nov;73(4):877-82
12213534
Eur J Neurosci. 2006 Aug;24(3):867-75
16930414
Dev Psychopathol. 2001 Summer;13(3):473-89
11523844
Pharmacol Biochem Behav. 1997 Sep;58(1):9-14
9264063
Psychoneuroendocrinology. 2015 Feb;52:168-75
25459899